Re: FDA accepts DYAX’s complete-response submission for DX-88
As an indication of the cluelessness of many biotech speculators in the post-VNDA era, I saw at least half a dozen posts today on various message boards asserting that DYAX had obtained “FDA approval” for DX-88. In other words, many people playing biotechs these days do not even understand the rudiments of the FDA approval process.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”